Impact of patient and public (PPI) involvement in the Life After Prostate Cancer Diagnosis (LAPCD) study: a mixed-methods study.

Jo Brett Zoe DaveyFiona MatleyHugh ButcherJohn KeenanDarryl CattonEila K WatsonPenny WrightAnna GavinAdam W Glaser

Published in: BMJ open (2022)

Including PPI as an integral component of the LAPCD study and providing the right context and mechanisms for involving the UAG helped maximise the programme's effectiveness and impact.

Keyphrases

prostate cancer
randomized controlled trial
case report
clinical trial
small molecule
double blind